Acer Therapeutics Inc. (ACER) [Rocket]

In millions, except per share items	Dec-31-22	Dec-31-21	Dec-31-20	Dec-31-19	Dec-31-18	Dec-31-17	Dec-31-16	Dec-31-15
	10-K	10-K	10-K	10-K	10-K	10-K	10-K	10-K
Assets
Cash and equivalents	2.3	12.7	5.8	12.1	41.7	15.6	1.8	12.6
Other current assets	1.2	15.4	0.7	0.8	1.1	0.9	0.5	0.5
Total current assets	3.5	28.1	6.4	12.9	42.7	16.5	2.4	13.1
Property, plant, and equipment, net	0.2	0.1	0.1	0.2	0.1	0.1	0.0	0.8
Goodwill	7.6	7.6	7.6	7.6	7.6	7.6	0.3
Other fixed assets	0.2	0.4	0.4	0.6	0.0	0.0	0.0	0.5
Total assets	11.6	36.3	14.6	21.5	50.7	24.4	2.8	14.4

Accounts payable	3.8	1.4	1.7	0.6	1.0	0.1	0.4	0.7
Accrued expenses	2.6	0.5	3.8	1.9	4.5	1.9	0.4	1.0
Short-term debt	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1
Short-term debt								0.1
Deferred revenues								2.9
Other current liabilities	12.5	27.2	0.7	0.3
Total current liabilities	19.0	29.1	6.1	2.8	5.6	2.0	0.8	4.8
Long-term debt	6.0
Other liabilities	3.4	8.9	0.2	0.3
Total liabilities	28.4	38.0	6.4	3.1	5.6	2.0	0.8	4.8

Shareholders' equity [+]	-16.8	-1.7	8.2	18.4	45.1	22.3	2.0	9.6
Paid-in capital	124.0	112.8	107.4	94.6	91.9	47.8	1.1	162.9
Retained earnings	-140.7	-114.5	-99.1	-76.3	-46.8	-25.6	-11.4	-153.3
Tangible shareholders' equity	-24.4	-9.4	0.6	10.7	37.4	14.7	1.7	9.6